AbL Diagnostics SA
ABLD.PA
| Exchange: | PA |
| Currency | Euro |
| ISIN: | FR001400AHX6 |
| Primary Ticker: | FAUV.PA |
| Fiscal Year End: | December |
| Sector: | Healthcare |
| Industry: | Health Information Services |
| Gic Sector: | Health Care |
| Gic Group: | Health Care Equipment & Services |
| Gic Industry: | Health Care Technology |
| Gic Sub Industry: | Health Care Technology |
| Description: | ABL Diagnostics Société anonyme provides proprietary molecular biology assays and end-to-end solutions to be used for molecular detection by polymerase chain reaction (PCR) and through DNA sequencing in France and internationally. It offers genotyping through NGS and sanger sequencing for human immunodeficiency virus, SARS Co V-2, hepatitis-C virus, mycobacterium tuberculosis, and 16S RNA; ultragene assays for viral detection of SARS Co V-2, dengue, and Zika virus; microbiological specimen transport and collection kits, which include RNA and saliva preservation, wastewater collection, and surface collection kits, as well as inactivation and preservation solution; and instrument and consumables, such as DNA/RNA extraction system, real-time PCR system, liquid handling robot, NGS library preparation system, and sanger sequencing reagents. The company also provides digital solutions comprising analysis software, data hosting, lab automation, Nadis, and Seq Hep B. It sells its products directly, as well as through a network of distributors to academic clinical pathology labs, private reference labs, and researchers. The company was formerly known as Etablissements Fauvet Girel and changed its name to ABL Diagnostics Société anonyme in April 2022. The company is based in Woippy, France. ABL Diagnostics Société anonyme is a subsidiary of Advanced Biological Laboratories (ABL) S.A. |
| Address: | 72c, rue de Thionville, Woippy, France, 57140 |
| Website: | https://www.abldiagnostics.com |
| Full Time Employees: | 20 |
| Updated On: | 2024-11-03 |
Highlights
| Market Capitalization: | 46035988 |
| Market Capitalization Mln: | 46.03 |
| EBITDA: | 428851 |
| Book Value: | 0.42 |
| Most Recent Quarter: | 2022-12-31 |
| Operating Margin TTM: | -0.16 |
| Return On Assets TTM: | -0.00 |
| Revenue TTM: | 6188712 |
| Revenue Per Share TTM: | 0.38 |
| Quarterly Revenue Growth YOY: | -0.64 |
| Gross Profit TTM: | 3094553 |
| Quarterly Earnings Growth YOY: | -0.93 |
Valuation
| Price Sales TTM: | 7.43 |
| Price Book MRQ: | 6.80 |
| Enterprise Value: | 47280054 |
| Enterprise Value Revenue: | 8.42 |
| Enterprise Value Ebitda: | 1040.83 |
Shares
| Shares Outstanding: | 16096500 |
| Shares Float: | 875146 |
| Percent Insiders: | 99.63 |
Technicals
| Beta: | -0.26 |
| 52 Week High: | 9.7 |
| 52 Week Low: | 2.7 |
| 50 Day MA: | 2.81 |
| 200 Day MA: | 4.07 |
Splits & Dividends
| Ex Dividend Date: | 2020-10-01 |
| Last Split Factor: | 8:1 |
| Last Split Date: | 2022-05-18 |
Earnings
| Report Date: | 2022-09-02 |
| Date: | 2022-06-30 |
| Currency: | EUR |
| Eps Actual: | -0.06 |
| Eps Difference: | -0.06 |
| Report Date: | 2022-05-20 |
| Date: | 2022-03-31 |
| Currency: | EUR |
| Eps Actual: | -0.02 |
| Eps Difference: | -0.02 |
| Report Date: | 2021-07-30 |
| Date: | 2021-06-30 |
| Currency: | EUR |
| Eps Actual: | 1.19 |
| Eps Difference: | 1.19 |
| Report Date: | 2021-04-23 |
| Date: | 2021-03-31 |
| Currency: | EUR |
| Eps Actual: | -0.21 |
| Eps Difference: | -0.21 |
| Report Date: | 2020-09-10 |
| Date: | 2020-06-30 |
| Currency: | EUR |
| Eps Actual: | -0.15 |
| Eps Difference: | -0.15 |
| Report Date: | 2020-06-23 |
| Date: | 2020-03-31 |
| Currency: | EUR |
| Eps Actual: | -0.13 |
| Eps Difference: | -0.13 |
| Report Date: | 2019-10-18 |
| Date: | 2019-09-30 |
| Currency: | EUR |
| Eps Actual: | -0.12 |
| Eps Difference: | -0.12 |
| Report Date: | 2019-05-03 |
| Date: | 2019-03-31 |
| Currency: | EUR |
| Eps Actual: | 6.47 |
| Eps Difference: | 6.47 |
| Report Date: | 2018-10-11 |
| Date: | 2018-09-30 |
| Currency: | EUR |
| Eps Actual: | -0.57 |
| Eps Difference: | -0.57 |
| Report Date: | 2018-05-18 |
| Date: | 2018-03-31 |
| Currency: | EUR |
| Eps Actual: | 0.71 |
| Eps Difference: | 0.71 |
| Report Date: | 2017-09-25 |
| Date: | 2017-06-30 |
| Currency: | EUR |
| Eps Actual: | -0.81 |
| Eps Difference: | -0.81 |
| Report Date: | 2017-04-13 |
| Date: | 2017-03-31 |
| Currency: | EUR |
| Eps Actual: | -1.11 |
| Eps Difference: | -1.11 |
| Date: | 2022-06-30 |
| Eps Actual: | 5.1 |